CD274 and cancer: As the PD-1/PD-L1 axis plays a major role in human cancers for immune evasion [17], it might be extremely valuable to cancer patients if prospective agents such as fucoidan devoid of side effects are available to regulate PD-L1 expression exclusively in cancer cells.